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Introduction: A high-quality health system should
deliver care that is free from harm. Few large-scale
studies of adverse events have been undertaken in
children’s healthcare internationally, and none in
Australia. The aim of this study is to measure the
frequency and types of adverse events encountered in
Australian paediatric care in a range of healthcare
settings.
Methods and analysis: A form of retrospective
medical record review, the Institute of Healthcare
Improvement’s Global Trigger Tool, will be modified to
collect data. Records of children aged <16 years
managed during 2012 and 2013 will be reviewed. We
aim to review 6000–8000 records from a sample of
healthcare practices (hospitals, general practices and
specialists).
Ethics and dissemination: Human Research Ethics
Committee approvals have been received from the
Sydney Children’s Hospital Network, Children’s Health
Queensland Hospital and Health Service, and the
Women’s and Children’s Hospital Network in South
Australia. An application is under review with the Royal
Australian College of General Practitioners. The authors
will submit the results of the study to relevant journals
and undertake national and international oral
presentations to researchers, clinicians and
policymakers.
INTRODUCTION
A high-quality health system should deliver
care that is free from harm.1 However, popu-
lation studies have shown that 10% of adult
hospital admissions are associated with
adverse events (AEs).2–4 For children, a
leading hospital in the USA found 37 AEs
per 100 admissions,5 while a multicentre
Canadian paediatric study using a validated
tool showed that 9.2% of patients experience
an AE, with higher rates recorded in aca-
demic centres when compared with commu-
nity settings.6 Few large-scale AE studies have
been undertaken internationally in chil-
dren’s healthcare, and none in Australia.
Retrospective medical record review (MRR)
can provide data on the frequency and type of
AEs.7 One method, the Global Trigger Tool
(GTT), initially developed in 2003 by the
Institute of Healthcare Improvement (IHI) for
use in hospitals,8 has been modiﬁed for paedi-
atric hospitals,5 6 9–11 neonatal intensive care
units,12 paediatric intensive care units,13 paedi-
atric otolaryngology14 and primary care.15–17
For general paediatric inpatients in North
America and Europe, the GTT has detected
6–37 AEs per 100 admissions.5 6 9 10 There are
no published studies using a GTT in
Australian paediatric care.
This research project (‘CareTrack Kids’—
CTK) involves three related aims and studies:
part 1—developing a set of clinical indicators
for common paediatric conditions; part 2—
measuring the appropriateness of paediatric care
in Australia using these clinical indicators; and
part 3—this study—measuring the frequency
Strengths and limitations of this study
▪ Data will be collected from a range of healthcare
practice types (hospital, general practice and
specialists).
▪ Collecting data from a range of healthcare prac-
tices and classifying the types of adverse events
encountered will allow priorities to be set as to
where improvement efforts are needed to reduce
harm to children.
▪ Potential selection bias for experts involved in the
development process of adverse event triggers.
▪ The use of a single surveyor to review the
medical record.
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and types of AEs encountered in Australian paediatric
care during 2012 and 2013. Study protocols describing
the methodology of the other two CTK studies are pre-
sented in separate protocol papers.18 19
This study is novel in that data will be collected from a
range of healthcare practice types (hospital, general
practice and specialists), which has never been under-
taken in adult or paediatric settings. Collecting data
from a range of healthcare practices and classifying the
type of AEs encountered will allow priorities to be set as
to where improvement efforts are needed to reduce
harm to children.20
METHODS AND ANALYSIS
There are nine components to the CTK AE study proto-
col (ﬁgure 1). Elements of component 1 (develop
inclusion criteria and sampling strategy), component 5
(recruit healthcare practices) and component 7 (train
and quality check data collectors and measuring inter-
rater reliability (IRR)) are described in more detail in
the part 2 CTK appropriateness of healthcare delivered
study protocol.18
Component 1: develop definitions, inclusion criteria,
sampling strategy and tools
Definitions
This study will use the deﬁnitions (box 1) for patient
safety from the WHO’s International Classiﬁcation for
Patient Safety (ICPS).21 They are recent, have been sub-
jected to formal development work and are inclusive
with few caveats. They also broadly align with those used
for the National Health Service (NHS) Institute for
Figure 1 Components of the CareTrack Kids (CTK) adverse event study.
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Improvement and Innovation’s Paediatric Trigger Tool,22
which facilitates making comparisons between countries.
Inclusion criteria
Medical records will be reviewed of children aged
<16 years managed for at least 1 of 16 CTK conditions,18
in one of three states of Australia: New South Wales
(NSW), Queensland (Qld) or South Australia (SA)
during 2012 and 2013.
Sampling strategy
We aim to review 6000–8000 records using a multistage,
randomised stratiﬁed sampling plan.18 The number of
MRRs that we propose is large compared with previous
paediatric GTT studies which range from 50 to 3992 and
average 1200.5 6 9–14 23 Our relatively large sample size
will enable analysis and characterisation of a large
number of types of AEs.20
Tools
We will use a modiﬁed version of the GTT8 to collect
data. GTTs use a series of ‘triggers’ to screen the record
for a potential AE. The presence of a trigger signals the
need for an in-depth review. AEs are coded according to
type, and AE rates are calculated. The original IHI
version of the GTT has been shown to have high speciﬁ-
city, moderate sensitivity and favourable inter-rater and
intra-rater reliability using hospital-based records for
adult patients.24
Component 2: collate and ratify triggers
Triggers applicable to Australian paediatric healthcare set-
tings will be developed. We will search the literature using
MEDLINE and CINAHL for the term ‘global trigger tool’
to collate existing tools and triggers. Examples of triggers
used previously in GTT studies6 10 17 25 include: clinical
events—transfusion or use of blood products, cardiac and
respiratory arrest; use of medications—vitamin K adminis-
tration, antiemetic use; laboratory investigations—positive
blood culture, glucose <2.8 mmol/L, rising blood urea
nitrogen or serum creatinine >2 times baseline; and
attendance or admissions—transfer to a higher level of
care, readmission within 30 days.
A set of candidate triggers will be collated, listing their
positive predictive values where available. Using a Delphi
process, clinical experts (members of the CTK team and
experts nominated by the team) will vote on the most
applicable triggers over two rounds. We will develop
three sets of triggers—one for hospital use (encompass-
ing emergency department visits and inpatient admis-
sions), one for general practice and one for specialist
clinics and ofﬁces, including outpatients. Clinical
experts will vote on their appropriate trigger sets.
Component 3: resolve data collection
requirements and structure
Data collection
A new module will be added to the web-based tool devel-
oped for the CareTrack Australia study26 27 to include
the collection of AEs. The purpose of the tool is to
enter data during MRR and enable subsequent data ana-
lysis. The tool will be on dedicated laptop computers
and support secure data access, data encryption, ofﬂine
data collection and subsequent database synchronisation
(to mitigate against the problems of ﬁre walls and poor
internet connectivity in various healthcare settings). The
tool will also support validation and conﬁrmation proce-
dures to measure IRR and workﬂows between research-
ers with a range of roles in reviewing records
(see component 8).
Data fields
If a trigger is positive, the following data ﬁelds will be
recorded: positive triggers (see component 2); a narra-
tive based on relevant information in the record; AE
origin; incident type;20 21 contributing factors; causation
(box 2); prevention (box 3); level of outcome or severity
Box 1 Definitions from the International Classification of
Patient Safety21
Patient safety is “the reduction of risk of unnecessary harm asso-
ciated with healthcare to an acceptable minimum. An acceptable
minimum refers to the collective notions of given current knowl-
edge, resources available and the context in which care was deliv-
ered weighed against the risk of non-treatment or other
treatment”
A patient safety incident is “an event or circumstance that could
have resulted, or did result, in unnecessary harm to a patient”.
The use of the word ‘unnecessary’ in this definition recognises
that errors, violation, patient abuse and deliberately unsafe acts
occur in healthcare. These are considered incidents. Certain
forms of harm, however, such as an incision for a laparotomy are
necessary. This is not considered an incident. Incidents arise
from either unintended or intended acts. Errors are, by definition,
unintentional, whereas violations are usually intentional, though
rarely malicious, and may become routine and automatic in
certain contexts
An adverse event is “an incident that results in harm to a
patient”.21 Harm “implies impairment of structure or function of
the body and/or any deleterious effect arising there from, includ-
ing disease, injury, suffering, disability and death, and may be
physical, social or psychological”21
Healthcare-associated harm is “harm arising from or associated
with plans or actions taken during the provision of healthcare,
rather than an underlying disease or injury”
Box 2 Healthcare management causation scale30 32
1=Virtually no evidence
2=Slight to modest evidence
3=Close call (less likely than not)
4=Close call (more likely than not)
5=Moderate or strong evidence
6=Virtually certain evidence
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(box 4); type of patient harm and ﬁelds to measure the
rate of AEs. These are described below.
The narrative
A brief medical history of the patient and the context
and circumstances in which the AE occurred will be
recorded.
Origin of AEs
The type of healthcare practice where the AE primarily
originated will be recorded. Previous studies have found
that AEs may occur at different practices or practice
types from where they are detected.17 25
Incident type
The incident type ICPS21 classiﬁcation will be recorded.
An incident type is a category made up of incidents of a
common nature, grouped because of shared agreed fea-
tures and is a ‘parent’ category under which many con-
cepts may be grouped (box 5).21 The beneﬁt of
collecting incident type is that this is the main method
of classifying what goes wrong into clinically useful cat-
egories.20 A brief free text descriptor of what happened
in the form of a ‘Principal Natural Category’(PNC)20
will be included, for example, delayed diagnosis of frac-
tured ulna, rash secondary to an adverse reaction to
measles, mumps and rubella vaccine.
Contributing factors
Contributing factors are the circumstances, actions or
inﬂuences which are thought to have played a part in
the origin or development of an incident or to increase
the risk of an incident.21 Examples include human
factors such as behaviour, performance or communica-
tion; system factors such as work environment; and exter-
nal factors beyond the direct control of the organisation,
such as the natural environment or legislative policy.21
More than one contributing factor or hazardous circum-
stance is typically involved in a patient safety incident.
We will develop and use the contributing factors classiﬁ-
cation based on existing systems.28 29
Causation
Causation is the degree to which harm is judged to have
been caused by healthcare management, rather than a
disease process or injury. Although the GTT8 does not
use a causation scale, we will apply a scale developed ori-
ginally for the Californian Medical Indemnity Feasibility
Study (MIFS)30 in the 1970s and the Harvard Medical
Practice Study (HMPS)31 32 and subsequent studies.
Other GTT studies have incorporated similar scales into
their protocols.6 33 Box 6 shows the questions that will
guide surveyors in determining the level of causation
while box 2 shows the causation scale. The study will
only include as AEs those scored between 4 and 6 for
causation.
Prevention
Prevention is the degree to which an AE can be
avoided.34 As with causation, the GTT8 does not use a
prevention scale. We will use the MIFS/HMPS scale,30–32
following other GTT studies.6 17 33 35 36 Box 7 shows the
questions which will guide surveyors in determining
levels of prevention in the HMPS while box 3 shows the
HMPS prevention scale.
There is considerable potential for differing interpre-
tations for both the causation and prevention scales
when reviewing records as with any implicit MRR.37 We
will implement robust quality assurance processes to
limit discrepancies between data collectors by training,
measuring inter-rater reliabilities and having regular
review meetings (see component 7).
Level of outcome or severity
Patient outcomes relate to the impact on a patient which is
wholly or partially attributable to an incident.20 These can
be classiﬁed according to the type of harm, the degree of
harm and any social and/or economic impact.20 The
National Coordinating Council for Medication Error
Reporting and Prevention (NCC-MERP) scale will be used
to score the outcome (box 4).38 This is the most frequently
used outcome classiﬁcation in studies using the GTT. Only
categories E–I are related to harm and will be considered
an AE (box 4).
Type of patient harm
The type of patient harm will be based on an existing
patient safety classiﬁcation which was developed from
incidents and previous AE studies.28 The detailed classiﬁ-
cation is shown in online supplementary appendix A.
The broad categories under clinical harm are patho-
physiological/disease-related, injury, psychological/emo-
tional distress, death and cardiorespiratory arrest. More
than one category can be used for each AE.
Box 3 Healthcare management prevention scale30 32
1=Virtually no evidence





Box 4 The National Coordinating Council for Medication
Error Reporting and Prevention (NCC-MERP) scale for
adverse event outcome38
Category E: Temporary harm to the patient requiring intervention
Category F: Temporary harm to the patient requiring initial or pro-
longed hospitalisation
Category G: Permanent patient harm
Category H: Intervention necessary to sustain life
Category I: Patient death
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Fields to measure AE rates
Depending on the healthcare practice type, different
ﬁelds (‘denominator data’) will be collected to enable
the AE rates to be calculated. For inpatients, the
number of occupied bed days (OBDs) for that admis-
sion (component 7) will be collected. For non-inpatients
(ie, records reviewed in general practice and specialists’
rooms), the denominator will be the number of consul-
tations reviewed (component 7).
Component 4: undertake pilot study
Given the complexity of collecting data over a geo-
graphic area and the need to conduct 6000–8000 MRRs
from at least three healthcare practice types, using three
sets of triggers, a pilot study will be undertaken. The
pilot study will assist in determining the types of issues
that might be encountered in evaluating the selection of
triggers, the data ﬁelds to be collected, the workﬂow and
interpretation of deﬁnitions and criteria for both sur-
veyors and reviewers, and the logistical and practical
aspects of recruiting healthcare practices, accessing
records and extracting, recording, storing and analysing
data.
Component 5: recruit healthcare practices
Major tertiary children’s hospitals, general hospitals
(metropolitan and regional), general practitioners, and
specialist paediatricians and psychiatrists will be invited
to participate in the research to allow MRRs to be
undertaken.18
Component 6: recruit surveyors and reviewers
Two types of researchers are required to complete the
ﬁnal AE data set—‘surveyors’ and ‘medical AE
reviewers’. Key selection criteria for both roles will be
experience in clinical audit and MRR together with
computer literacy. Nurses will be employed to simultan-
eously act as surveyors for this study and CTK part 2
(appropriateness).18 We estimate that eight full-time
equivalent staff will be required. The selection process
will involve an aptitude test using triggers and detection
of AEs in artiﬁcially constructed medical records.26 27
Medical practitioners will be recruited as ‘medical AE
reviewers’ to undertake a conﬁrmation review of the
information collected and recorded by the surveyor. Six
doctors with paediatric experience and who fulﬁl the
key selection criteria will be recruited.
The use of a single surveyor is a modiﬁcation of the
original GTT method8 which used two surveyors and
one reviewer per MRR. While some GTT studies have
used the original method,5 11 33 35 39 a variety of other
models have been used including one surveyor and two
reviewers,36 computerised screening,40 and one surveyor
and one reviewer.23
Component 7: train and quality check data collectors and
measure IRR
Details on educational interventions, instructions and
teleconference supports to align rules and reduce vari-
ability between surveyors and medical AE reviewers are
outlined in the CTK appropriateness protocol.18 Dual
MRRs will be undertaken for a sample comparing
Box 5 International Classification of Patient Safety
Incident Types21
Clinical administration






Oxygen, gas or vapour





Resources and organisational management
Box 6 Questions to guide surveyors to determine the
level of causation30 32
Is there a note in the medical record which indicates or suggests
that healthcare management caused the injury?
Is there a note in the medical record which predicts the possibility
of an injury from the patient’s disease?
Does the timing of events suggest that the injury was related to
the treatment?
Are there other reasonable explanations for the cause of the
injury?
Was there an opportunity prior to the occurrence of the injury for
intervention which might have prevented it?
Is there recognition that the intervention in question causes this
kind of injury?
Did the AE respond to new management to neutralise or modify
the effects of former management?
Box 7 Questions to guide surveyors to determine the
level of prevention30 32
Is there consensus about diagnosis and therapy regarding this
case?
How complex was the case?
Was the management in question appropriate?
What was the comorbidity of the case in which the AE occurred?
What was the degree of deviation of management from the
accepted norm?
What was the degree of emergency in management of the case
prior to the occurrence of the AE?
What potential benefit was associated with the management?
What was the chance of benefit associated with the
management?
What was the risk of an adverse event related to the
management?
On reflection, would a reasonable doctor or health professional
do this again?
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ﬁndings to those of a CTK research team member.18
IRR will be measured at a number of points including
between dual surveyor reviews for a sample, between sur-
veyor and medical AE reviews with respect to whether an
AE has occurred, incident type, and causation, preven-
tion and outcome scores.
Component 8: undertake medical record reviews
MRRs will be conducted for a randomly selected hos-
pital index admission. All general practice and specialist
consultations undertaken during 2012 and 2013 will be
reviewed. All available information relating to the index
admission will be reviewed including discharge summar-
ies and letters.8
If no triggers are detected, no further action will be
taken by the surveyor and the review will be considered
complete. If one or more triggers are detected, the sur-
veyor will undertake an in-depth MRR to search for AEs.
If a surveyor detects a potential AE, they will record all
data ﬁelds outlined in component 3.
When a surveyor has recorded a potential AE, the web-
based tool will electronically notify a medical AE
reviewer (see component 3). The reviewer will then be
able to securely enter the web-based tool, review the
information supplied by the surveyor, and provide a
determination as to the presence of an AE. For con-
ﬁrmed AEs, a medical AE reviewer will record incident
type, and causation, prevention and outcome scores.
Component 9: analyse data
Data capture will be structured to allow identiﬁcation of
incident types (see component 3) and calculation of AE
rates. CIs will be calculated and stratiﬁcation will be
undertaken by healthcare practice type.
The primary outcome measures for inpatients will be
the number of AEs per 100 admissions, the percentage
of admissions with an AE and the rate per 1000 OBDs.
We are collecting all three measures to allow compari-
sons with other GTT studies as there is no consensus on
which metric to use. The ﬁrst two are likely to be more
intuitive for the lay public and policymakers, while the
latter is a more accurate indicator of risk exposure and
may be more acceptable to clinicians. For general prac-
tices and specialists, the number of AEs per 100 consul-
tations will be calculated. Secondary outcome measures
will include scores for preventability, causation, contrib-
uting factors and outcomes (severity).
ETHICS AND DISSEMINATION
Ethics
Relevant Human Research Ethics Committee (HREC)
approvals have been secured and Site Speciﬁc Approvals
will be sought and received prior to participant and
healthcare practice recruitment and MRRs in all jurisdic-
tions, authorities and health services. Single ethical
review has been obtained from a lead HREC in each
state in order to provide ethical approval for the
hospitals within that state. The lead HRECs include:
Sydney Children’s Hospitals Network (15 NSW hospitals),
Queensland Royal Children’s Hospital (12 Qld hospitals)
and Women’s and Children’s Hospital Network (8 SA
hospitals). Site-speciﬁc approvals will be sought from
each hospital. The Royal College of General
Practitioners National Research and Ethics Evaluation
Committee application is under review.
As part of the HREC application, we are proposing
that patient and individual healthcare practice consent
be waived as it complies with the NHMRC “Guidelines
approved under Section 95A of the Privacy Act 1988”41
and the NHMRC Chapter 2.3.10 “Qualifying or waiving
conditions for consent”.42 In summary, the study
involves: minimal risk to healthcare practices and partici-
pants and cannot be achieved without access to records;
with dispersed geographic regions across three states,
the large number of healthcare practices and records
(6000–8000), it is logistically difﬁcult to obtain consent;
information is retrospective and there is no likely reason
patients would not consent; data are entered directly
onto a database which will not contain personal informa-
tion; and only aggregated data will be disseminated.
Statutory immunity
Statutory immunity protects from disclosure any identify-
ing information obtained through an approved quality
assurance activity.43 CTK has applied to the Federal
(Commonwealth) Minister for Health for statutory
immunity under Section VC of the Commonwealth
Health Insurance Act 1973.
Dissemination
We will submit the results of the study to relevant
national and international journals with the intention of
publishing the results widely. Also, we will make national
and international oral presentations to stakeholder
groups including those involving patients, researchers,
clinicians, managers and policymakers.
DISCUSSION
A selection bias may be introduced as practices which
agree to participate in the study may have a higher rate
of participation in research, proactive audit and existing
feedback processes. These factors may affect AE rates or
the quality of AE documentation in the medical record.
The use of a single reviewer to undertake the MRR may
also be a limitation. Dual surveyor reviews and measure-
ment of IRR will be undertaken to minimise this
limitation.
In conclusion, this study will measure the frequency
and types of AEs encountered in Australian paediatric
care in a range of healthcare settings. There have been
few large-scale studies of AEs undertaken in children’s
healthcare internationally, and none in Australia. This
study will allow priorities to be set as to where improve-
ment efforts are needed to reduce harm to children.
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